Maximus, Inc. $MMS Position Boosted by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Maximus by 45.9% to 66,837 shares (about $5.78M) in Q4, and institutional investors now own roughly 97.21% of the company.
• Insider buying: CEO Bruce Caswell purchased 3,175 shares at $78.45 (now owns 328,013 shares) and CFO David Mutryn bought 1,000 shares at $75.62 (now owns 40,037), with insiders holding about 1.80% of the stock.
• Maximus slightly beat quarterly EPS ($1.85 vs. $1.84) while revenue fell 4.1% year‑over‑year; management set FY2026 guidance of $8.05–$8.35 EPS, and the company declared a $0.33 quarterly dividend (annualized yield ~2.0%).

Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 45.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,837 shares of the health services provider's stock after buying an additional 21,013 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.12% of Maximus worth $5,782,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Maximus by 11.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,011 shares of the health services provider's stock valued at $1,641,000 after acquiring an additional 1,928 shares during the last quarter. GHP Investment Advisors Inc. lifted its position in shares of Maximus by 2.4% during the 4th quarter. GHP Investment Advisors Inc. now owns 29,309 shares of the health services provider's stock valued at $2,530,000 after acquiring an additional 679 shares during the last quarter. Farther Finance Advisors LLC lifted its position in shares of Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider's stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Richardson Financial Services Inc. lifted its position in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider's stock valued at $39,000 after acquiring an additional 103 shares during the last quarter. Finally, Westbourne Investments Inc. acquired a new stake in shares of Maximus during the 4th quarter valued at $388,000. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity at Maximus

In related news, CEO Bruce Caswell purchased 3,175 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was acquired at an average price of $78.45 per share, with a total value of $249,078.75. Following the completion of the acquisition, the chief executive officer directly owned 328,013 shares in the company, valued at approximately $25,732,619.85. This trade represents a 0.98% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO David Mutryn acquired 1,000 shares of the business's stock in a transaction that occurred on Monday, February 9th. The stock was acquired at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer directly owned 40,037 shares of the company's stock, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 1.80% of the stock is currently owned by company insiders.

Maximus Price Performance

NYSE MMS opened at $65.10 on Tuesday. Maximus, Inc. has a fifty-two week low of $60.75 and a fifty-two week high of $100.00. The stock's 50-day moving average is $69.81 and its two-hundred day moving average is $80.83. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34. The firm has a market cap of $3.55 billion, a P/E ratio of 9.91 and a beta of 0.63.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same period in the prior year, the firm earned $1.61 EPS. Maximus's quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts anticipate that Maximus, Inc. will post 8.46 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. Maximus's dividend payout ratio (DPR) is currently 20.09%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on MMS shares. Zacks Research upgraded Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, December 30th. Weiss Ratings lowered shares of Maximus from a "buy (b)" rating to a "hold (c+)" rating in a research note on Tuesday, February 24th. Finally, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Monday, February 23rd. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, Maximus has an average rating of "Buy".

About Maximus

Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.